| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TSPAN12 OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 CHRND OPRK1 OPRM1 TLR6 MTNR1A | 6.78e-16 | 1353 | 20 | 16 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 OPRK1 OPRM1 MTNR1A | 1.34e-13 | 884 | 20 | 13 | GO:0004930 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 3.01e-12 | 431 | 20 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 2.00e-05 | 7 | 20 | 2 | GO:0004985 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.77e-04 | 129 | 20 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.33e-04 | 343 | 20 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.40e-04 | 151 | 20 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 6.22e-04 | 37 | 20 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 9.97e-04 | 459 | 20 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | channel activity | 1.64e-03 | 525 | 20 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.65e-03 | 526 | 20 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | peptide binding | 3.73e-03 | 318 | 20 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.84e-03 | 664 | 20 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 7.19e-03 | 793 | 20 | 4 | GO:0015075 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 7.73e-03 | 133 | 20 | 2 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 8.54e-03 | 140 | 20 | 2 | GO:0001653 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.07e-02 | 465 | 20 | 3 | GO:0046873 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.28e-02 | 173 | 20 | 2 | GO:0070851 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 TLR6 | 3.50e-13 | 524 | 20 | 11 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 2.24e-12 | 432 | 20 | 10 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 4.65e-12 | 465 | 20 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 7.05e-12 | 485 | 20 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 TLR6 | 1.13e-11 | 722 | 20 | 11 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 2.31e-11 | 547 | 20 | 10 | GO:0007606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 OPRK1 OPRM1 MTNR1A | 2.91e-11 | 1395 | 20 | 13 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 OPRK1 OPRM1 | 3.13e-11 | 1072 | 20 | 12 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 4.25e-11 | 582 | 20 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting opioid receptor signaling pathway | 2.68e-06 | 3 | 20 | 2 | GO:0031635 | |
| GeneOntologyBiologicalProcess | negative regulation of luteinizing hormone secretion | 1.34e-05 | 6 | 20 | 2 | GO:0033685 | |
| GeneOntologyBiologicalProcess | regulation of luteinizing hormone secretion | 4.00e-05 | 10 | 20 | 2 | GO:0033684 | |
| GeneOntologyBiologicalProcess | reproductive behavior | 4.84e-05 | 74 | 20 | 3 | GO:0019098 | |
| GeneOntologyBiologicalProcess | negative regulation of gonadotropin secretion | 4.89e-05 | 11 | 20 | 2 | GO:0032277 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 6.92e-05 | 13 | 20 | 2 | GO:0038003 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 7.58e-05 | 86 | 20 | 3 | GO:0007193 | |
| GeneOntologyBiologicalProcess | luteinizing hormone secretion | 8.07e-05 | 14 | 20 | 2 | GO:0032275 | |
| GeneOntologyBiologicalProcess | regulation of gonadotropin secretion | 1.06e-04 | 16 | 20 | 2 | GO:0032276 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone secretion | 1.30e-04 | 103 | 20 | 3 | GO:0046888 | |
| GeneOntologyBiologicalProcess | gonadotropin secretion | 2.04e-04 | 22 | 20 | 2 | GO:0032274 | |
| MousePheno | impaired behavioral response to anesthetic | 4.60e-06 | 5 | 10 | 2 | MP:0009778 | |
| MousePheno | impaired behavioral response to morphine | 2.07e-05 | 10 | 10 | 2 | MP:0009757 | |
| MousePheno | abnormal behavioral response to anesthetic | 3.03e-05 | 12 | 10 | 2 | MP:0009777 | |
| MousePheno | abnormal behavioral response to morphine | 3.58e-05 | 13 | 10 | 2 | MP:0020159 | |
| MousePheno | decreased chemically-elicited antinociception | 7.83e-05 | 19 | 10 | 2 | MP:0001982 | |
| MousePheno | abnormal chemically-elicited antinociception | 1.85e-04 | 29 | 10 | 2 | MP:0001980 | |
| MousePheno | impaired behavioral response to addictive substance | 4.49e-04 | 45 | 10 | 2 | MP:0009750 | |
| Domain | GPCR_Rhodpsn_7TM | OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 OPRK1 OPRM1 MTNR1A | 1.65e-13 | 670 | 19 | 12 | IPR017452 |
| Domain | 7tm_1 | OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 OPRK1 OPRM1 MTNR1A | 1.87e-13 | 677 | 19 | 12 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 OPRK1 OPRM1 MTNR1A | 2.15e-13 | 685 | 19 | 12 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 OPRK1 OPRM1 MTNR1A | 2.38e-13 | 691 | 19 | 12 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 OPRK1 OPRM1 MTNR1A | 2.42e-13 | 692 | 19 | 12 | IPR000276 |
| Domain | Olfact_rcpt | 5.66e-11 | 393 | 19 | 9 | IPR000725 | |
| Domain | Opioid_rcpt | 5.88e-06 | 4 | 19 | 2 | IPR001418 | |
| Domain | 7TM_GPCR_Srsx | 1.90e-04 | 112 | 19 | 3 | SM01381 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 3.36e-11 | 417 | 19 | 10 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 6.12e-10 | 389 | 19 | 9 | M14091 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 2.08e-09 | 636 | 19 | 10 | M41834 |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 2.60e-04 | 18 | 19 | 2 | M27901 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 4.18e-04 | 272 | 19 | 4 | M13380 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 1.18e-15 | 340 | 20 | 10 | 11875048 |
| Pubmed | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 1.18e-15 | 340 | 20 | 10 | 11802173 | |
| Pubmed | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 1.29e-15 | 343 | 20 | 10 | 32295537 | |
| Pubmed | OR4A8 OR2T4 OR4C11 OR4C16 OR6Y1 OR4A16 OR4C12 OR2M5 OR9Q2 OR2M3 | 1.41e-15 | 346 | 20 | 10 | 14611657 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 2.85e-12 | 74 | 20 | 6 | 15081110 | |
| Pubmed | 7.20e-12 | 541 | 20 | 9 | 14983052 | ||
| Pubmed | Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors. | 3.14e-07 | 2 | 20 | 2 | 24651466 | |
| Pubmed | κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage. | 3.14e-07 | 2 | 20 | 2 | 31940240 | |
| Pubmed | Differential involvement of the mu and kappa opioid receptors in spatial learning. | 3.14e-07 | 2 | 20 | 2 | 12884965 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 16530171 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 28512665 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 27838450 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 22138325 | ||
| Pubmed | Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors. | 3.14e-07 | 2 | 20 | 2 | 16954126 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 27958613 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 17185983 | ||
| Pubmed | Ligand directed signaling differences between rodent and human κ-opioid receptors. | 3.14e-07 | 2 | 20 | 2 | 23086943 | |
| Pubmed | Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphisms. | 9.42e-07 | 3 | 20 | 2 | 26946441 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 19032295 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 31806881 | ||
| Pubmed | Nociception increases during opioid infusion in opioid receptor triple knock-out mice. | 9.42e-07 | 3 | 20 | 2 | 17544222 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 15090050 | ||
| Pubmed | Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. | 9.42e-07 | 3 | 20 | 2 | 14745298 | |
| Pubmed | Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. | 9.42e-07 | 3 | 20 | 2 | 8114680 | |
| Pubmed | Opioid receptor characterisation of neuronally stimulated isolated human vas deferens. | 9.42e-07 | 3 | 20 | 2 | 22752269 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 11032994 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 10082819 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 25855262 | ||
| Pubmed | Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. | 9.42e-07 | 3 | 20 | 2 | 18338799 | |
| Pubmed | Opioid receptors: from binding sites to visible molecules in vivo. | 9.42e-07 | 3 | 20 | 2 | 18718480 | |
| Pubmed | Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. | 9.42e-07 | 3 | 20 | 2 | 18537939 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 23220294 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 12603260 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 17676326 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 24874714 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 26692286 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 17374034 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 30365572 | ||
| Pubmed | Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. | 9.42e-07 | 3 | 20 | 2 | 11826143 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 18213616 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 33555255 | ||
| Pubmed | Enhanced humoral response in kappa-opioid receptor knockout mice. | 9.42e-07 | 3 | 20 | 2 | 12507774 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 14975676 | ||
| Pubmed | Quantitative trait loci influencing morphine antinociception in four mapping populations. | 9.42e-07 | 3 | 20 | 2 | 11420618 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 11504820 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 15178356 | ||
| Pubmed | Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. | 9.42e-07 | 3 | 20 | 2 | 12431223 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 9572309 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 28049031 | ||
| Pubmed | Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. | 9.42e-07 | 3 | 20 | 2 | 11069979 | |
| Pubmed | Formalin-induced pain is reduced in sigma(1) receptor knockout mice. | 9.42e-07 | 3 | 20 | 2 | 15777781 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 17997230 | ||
| Pubmed | High-throughput microarray detection of olfactory receptor gene expression in the mouse. | 1.88e-06 | 4 | 20 | 2 | 15377787 | |
| Pubmed | Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. | 1.88e-06 | 4 | 20 | 2 | 8941707 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 16053916 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 12413885 | ||
| Pubmed | Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. | 1.88e-06 | 4 | 20 | 2 | 9502813 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 11430857 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 30249798 | ||
| Pubmed | Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. | 3.14e-06 | 5 | 20 | 2 | 20534436 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 33782947 | ||
| Pubmed | Variations in opioid receptor genes in neonatal abstinence syndrome. | 3.14e-06 | 5 | 20 | 2 | 26233486 | |
| Pubmed | Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. | 4.71e-06 | 6 | 20 | 2 | 9746745 | |
| Pubmed | Genetic susceptibility to heroin addiction: a candidate gene association study. | 4.71e-06 | 6 | 20 | 2 | 18518925 | |
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 12044478 | ||
| Pubmed | Preimplantation mouse embryo is a target for opioid ligand-receptor signaling. | 8.78e-06 | 8 | 20 | 2 | 24855103 | |
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 18591429 | ||
| Pubmed | Murine chromosomal location of the mu and kappa opioid receptor genes. | 1.13e-05 | 9 | 20 | 2 | 7959748 | |
| Pubmed | Chromosomal localization of opioid peptide and receptor genes in the mouse. | 2.07e-05 | 12 | 20 | 2 | 7752808 | |
| Pubmed | Identification of a novel family of G protein-coupled receptor associated sorting proteins. | 2.85e-05 | 14 | 20 | 2 | 15086532 | |
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 23840749 | ||
| Pubmed | 4.25e-05 | 17 | 20 | 2 | 21483469 | ||
| Pubmed | Gsh2 and Pax6 play complementary roles in dorsoventral patterning of the mammalian telencephalon. | 7.21e-05 | 22 | 20 | 2 | 11124115 | |
| Pubmed | 1.43e-04 | 179 | 20 | 3 | 18577758 | ||
| Pubmed | 1.54e-04 | 32 | 20 | 2 | 23817571 | ||
| Pubmed | 2.18e-04 | 38 | 20 | 2 | 22908908 | ||
| Pubmed | 3.20e-04 | 46 | 20 | 2 | 32126975 | ||
| Pubmed | A large-scale candidate gene association study of age at menarche and age at natural menopause. | 5.05e-04 | 275 | 20 | 3 | 20734064 | |
| Pubmed | 5.09e-04 | 58 | 20 | 2 | 11140838 | ||
| Interaction | GJA4 interactions | 1.22e-05 | 10 | 11 | 2 | int:GJA4 | |
| Interaction | WLS interactions | 1.53e-05 | 93 | 11 | 3 | int:WLS | |
| Interaction | GNA15 interactions | 8.74e-05 | 26 | 11 | 2 | int:GNA15 | |
| Interaction | OPRD1 interactions | 3.40e-04 | 51 | 11 | 2 | int:OPRD1 | |
| Interaction | CLEC7A interactions | 3.82e-04 | 54 | 11 | 2 | int:CLEC7A | |
| Interaction | CCDC167 interactions | 4.56e-04 | 59 | 11 | 2 | int:CCDC167 | |
| Interaction | CTXN3 interactions | 4.71e-04 | 60 | 11 | 2 | int:CTXN3 | |
| Interaction | SERP2 interactions | 5.19e-04 | 63 | 11 | 2 | int:SERP2 | |
| Interaction | DEGS1 interactions | 5.87e-04 | 67 | 11 | 2 | int:DEGS1 | |
| Interaction | GPRASP1 interactions | 5.87e-04 | 67 | 11 | 2 | int:GPRASP1 | |
| Interaction | EMP3 interactions | 6.23e-04 | 69 | 11 | 2 | int:EMP3 | |
| Interaction | PMP22 interactions | 6.41e-04 | 70 | 11 | 2 | int:PMP22 | |
| Interaction | DOK4 interactions | 7.16e-04 | 74 | 11 | 2 | int:DOK4 | |
| Interaction | ADAM33 interactions | 8.16e-04 | 79 | 11 | 2 | int:ADAM33 | |
| Interaction | COG1 interactions | 8.16e-04 | 79 | 11 | 2 | int:COG1 | |
| Interaction | MAL interactions | 8.78e-04 | 82 | 11 | 2 | int:MAL | |
| Interaction | SLC38A7 interactions | 1.01e-03 | 88 | 11 | 2 | int:SLC38A7 | |
| Interaction | SIAH2 interactions | 1.41e-03 | 104 | 11 | 2 | int:SIAH2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q11 | 2.37e-09 | 40 | 20 | 4 | chr11q11 | |
| Cytoband | 11q11 | 1.13e-06 | 47 | 20 | 3 | 11q11 | |
| Cytoband | 1q44 | 1.48e-05 | 110 | 20 | 3 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 2.33e-05 | 128 | 20 | 3 | chr1q44 | |
| Cytoband | 11p11.12 | 1.54e-04 | 42 | 20 | 2 | 11p11.12 | |
| GeneFamily | Olfactory receptors, family 4 | 1.36e-07 | 129 | 18 | 5 | 151 | |
| GeneFamily | Opioid receptors | 5.61e-06 | 4 | 18 | 2 | 245 | |
| GeneFamily | Olfactory receptors, family 2 | 1.81e-04 | 113 | 18 | 3 | 149 | |
| Coexpression | DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS | 2.60e-05 | 12 | 17 | 2 | M40089 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP | 2.71e-04 | 199 | 17 | 3 | M5526 | |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN | 2.75e-04 | 200 | 17 | 3 | M6366 | |
| Coexpression | GSE17721_4_VS_24H_CPG_BMDC_UP | 2.75e-04 | 200 | 17 | 3 | M4130 | |
| Coexpression | GSE10325_CD4_TCELL_VS_MYELOID_DN | 2.75e-04 | 200 | 17 | 3 | M3079 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.70e-05 | 113 | 20 | 3 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-05 | 185 | 20 | 3 | 2088e82e0febdcf05618d3db913d00e2e87812f4 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.40e-05 | 193 | 20 | 3 | de569c6e507856fd3ac2311f246cb597074ed30c | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 198 | 20 | 3 | 1eb49b853a9e144e840c660060473fc7873f6478 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.19e-05 | 199 | 20 | 3 | 494461665f945ce6c97299c58f7785e90dec5812 | |
| Computational | Vesicular transport / synapse genes. | 5.66e-04 | 82 | 5 | 2 | MODULE_274 | |
| Drug | Dcfpe | 5.47e-07 | 21 | 18 | 3 | CID003082858 | |
| Drug | N-propargyl | 5.90e-07 | 2 | 18 | 2 | ctd:C440369 | |
| Drug | N-(3-iodoprop-(2)-enyl) | 5.90e-07 | 2 | 18 | 2 | ctd:C440388 | |
| Drug | methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate | 5.90e-07 | 2 | 18 | 2 | ctd:C533093 | |
| Drug | Cyclazocine | 5.90e-07 | 2 | 18 | 2 | ctd:D003496 | |
| Drug | paynantheine | 5.90e-07 | 2 | 18 | 2 | ctd:C580857 | |
| Drug | 3-dadh-ol | 5.90e-07 | 2 | 18 | 2 | CID000128663 | |
| Drug | Dezocine | 5.90e-07 | 2 | 18 | 2 | DB01209 | |
| Drug | dihydroheroin | 5.90e-07 | 2 | 18 | 2 | CID005359460 | |
| Drug | GUM1 compound | 5.90e-07 | 2 | 18 | 2 | ctd:C000611307 | |
| Drug | P 7521 | 5.90e-07 | 2 | 18 | 2 | CID000146384 | |
| Drug | tetrahydro-3-isoquinolinecarboxylic acid | 9.44e-07 | 25 | 18 | 3 | CID000095489 | |
| Drug | Alvimopan | 1.77e-06 | 3 | 18 | 2 | DB06274 | |
| Drug | Pentazocine | 1.77e-06 | 3 | 18 | 2 | ctd:D010423 | |
| Drug | Buprenorphine | 1.77e-06 | 3 | 18 | 2 | DB00921 | |
| Drug | dextrallorphan | 1.77e-06 | 3 | 18 | 2 | ctd:C044130 | |
| Drug | cyclorphan | 1.77e-06 | 3 | 18 | 2 | ctd:C084603 | |
| Drug | Heroin | 1.77e-06 | 3 | 18 | 2 | DB01452 | |
| Drug | 3-Methylthiofentanyl | 1.77e-06 | 3 | 18 | 2 | DB01439 | |
| Drug | 14-phenylpropoxymetopon | 1.77e-06 | 3 | 18 | 2 | ctd:C478565 | |
| Drug | morphine-7,8-oxide | 1.77e-06 | 3 | 18 | 2 | CID005491901 | |
| Drug | TRK 820 | 1.77e-06 | 3 | 18 | 2 | ctd:C111212 | |
| Drug | Levorphanol | 1.77e-06 | 3 | 18 | 2 | DB00854 | |
| Drug | Levorphanol | 1.77e-06 | 3 | 18 | 2 | ctd:D007981 | |
| Drug | Levallorphan | 1.77e-06 | 3 | 18 | 2 | ctd:D007977 | |
| Drug | Remifentanil | 1.77e-06 | 3 | 18 | 2 | DB00899 | |
| Drug | Nalbuphine | 1.77e-06 | 3 | 18 | 2 | DB00844 | |
| Drug | Fentanyl | 1.77e-06 | 3 | 18 | 2 | DB00813 | |
| Drug | Oxycodone | 1.77e-06 | 3 | 18 | 2 | DB00497 | |
| Drug | Hydromorphone | 1.77e-06 | 3 | 18 | 2 | DB00327 | |
| Drug | Codeine | 1.77e-06 | 3 | 18 | 2 | DB00318 | |
| Drug | Lactoferroxin C | 1.77e-06 | 3 | 18 | 2 | CID000192714 | |
| Drug | Lactoferroxin B | 1.77e-06 | 3 | 18 | 2 | CID000192715 | |
| Drug | Lactoferroxin A | 1.77e-06 | 3 | 18 | 2 | CID000192716 | |
| Drug | Sufentanil | 1.77e-06 | 3 | 18 | 2 | DB00708 | |
| Drug | Propoxyphene | 1.77e-06 | 3 | 18 | 2 | DB00647 | |
| Drug | Butorphanol | 1.77e-06 | 3 | 18 | 2 | DB00611 | |
| Drug | bromadoline | 1.77e-06 | 3 | 18 | 2 | CID000054753 | |
| Drug | Carfentanil | 1.77e-06 | 3 | 18 | 2 | DB01535 | |
| Drug | Butorphanol | 1.77e-06 | 3 | 18 | 2 | ctd:D002077 | |
| Drug | Pentazocine | 1.77e-06 | 3 | 18 | 2 | DB00652 | |
| Drug | Morphine | 1.77e-06 | 3 | 18 | 2 | DB00295 | |
| Drug | Hydrocodone | 1.77e-06 | 3 | 18 | 2 | ctd:D006853 | |
| Drug | 3-Methylfentanyl | 1.77e-06 | 3 | 18 | 2 | DB01571 | |
| Drug | 7-hydroxymitragynine | 3.54e-06 | 4 | 18 | 2 | ctd:C482678 | |
| Drug | NSC1953 | 3.54e-06 | 4 | 18 | 2 | CID000102946 | |
| Drug | 3B-b | 3.54e-06 | 4 | 18 | 2 | CID000533975 | |
| Drug | Nalbuphine | 3.54e-06 | 4 | 18 | 2 | ctd:D009266 | |
| Drug | diphenoxylate | 3.54e-06 | 4 | 18 | 2 | CID000013505 | |
| Drug | Dynorphins | 3.54e-06 | 4 | 18 | 2 | ctd:D004399 | |
| Drug | Naltrexone | 3.54e-06 | 4 | 18 | 2 | DB00704 | |
| Drug | Meperidine | 3.54e-06 | 4 | 18 | 2 | ctd:D008614 | |
| Drug | Methadyl Acetate | 3.54e-06 | 4 | 18 | 2 | ctd:D008692 | |
| Drug | AC1L5BQM | 3.54e-06 | 4 | 18 | 2 | CID000174892 | |
| Drug | Diprenorphine | 3.54e-06 | 4 | 18 | 2 | DB01548 | |
| Drug | K 185 | 5.89e-06 | 5 | 18 | 2 | CID005311198 | |
| Drug | nalorphine-epoxide | 5.89e-06 | 5 | 18 | 2 | CID003086440 | |
| Drug | oxymorphamine | 5.89e-06 | 5 | 18 | 2 | CID000134844 | |
| Drug | Sc 39566 | 5.89e-06 | 5 | 18 | 2 | CID000130018 | |
| Drug | nalmefene | 5.89e-06 | 5 | 18 | 2 | ctd:C038981 | |
| Drug | Naloxone | 5.89e-06 | 5 | 18 | 2 | DB01183 | |
| Drug | Dihydromorphine | 5.89e-06 | 5 | 18 | 2 | DB01565 | |
| Drug | AC1L2OET | 8.84e-06 | 6 | 18 | 2 | CID000125331 | |
| Drug | Etorphine | 8.84e-06 | 6 | 18 | 2 | DB01497 | |
| Drug | Loperamide | 8.84e-06 | 6 | 18 | 2 | DB00836 | |
| Drug | NSC612111 | 8.84e-06 | 6 | 18 | 2 | CID000163346 | |
| Drug | RX8008M | 8.84e-06 | 6 | 18 | 2 | CID000162443 | |
| Drug | 2-mercaptoacetate | 1.24e-05 | 7 | 18 | 2 | ctd:C017487 | |
| Drug | AC1L9PCU | 1.24e-05 | 7 | 18 | 2 | CID000451042 | |
| Drug | N-cyclopropylmethylnorazidomorphine | 1.24e-05 | 7 | 18 | 2 | CID005489191 | |
| Drug | beta-naltrexamine | 1.24e-05 | 7 | 18 | 2 | CID005486948 | |
| Drug | Pcl-dpdpe | 1.24e-05 | 7 | 18 | 2 | CID000159564 | |
| Drug | aminocyclohexanecarboxylic acid | 1.24e-05 | 7 | 18 | 2 | CID000171560 | |
| Drug | Tyr-ala-phe-gly | 1.24e-05 | 7 | 18 | 2 | CID005487532 | |
| Drug | Enkephalin, D-Penicillamine (2,5)- | 1.24e-05 | 7 | 18 | 2 | ctd:D020881 | |
| Drug | Dextrorphan | 1.24e-05 | 7 | 18 | 2 | ctd:D003917 | |
| Drug | MET-CAMO | 1.24e-05 | 7 | 18 | 2 | CID006450159 | |
| Drug | Dextropropoxyphene | 1.24e-05 | 7 | 18 | 2 | ctd:D011431 | |
| Drug | phenylmorphan | 1.24e-05 | 7 | 18 | 2 | CID000146306 | |
| Drug | NDTMB | 1.24e-05 | 7 | 18 | 2 | CID000134748 | |
| Drug | AC1L9NAZ | 1.54e-05 | 198 | 18 | 4 | CID000449606 | |
| Drug | meperidine | 1.60e-05 | 63 | 18 | 3 | CID000004058 | |
| Drug | beta-MeTrp | 1.65e-05 | 8 | 18 | 2 | CID000065530 | |
| Drug | DIPPA | 1.65e-05 | 8 | 18 | 2 | CID000127914 | |
| Drug | ICI 204448 | 1.65e-05 | 8 | 18 | 2 | CID000003683 | |
| Drug | 14-methoxymetopon | 1.65e-05 | 8 | 18 | 2 | CID005486940 | |
| Drug | Oxymorphone hydrazone | 1.65e-05 | 8 | 18 | 2 | CID009577748 | |
| Drug | U 69593 | 1.65e-05 | 8 | 18 | 2 | ctd:C045444 | |
| Drug | metazocine | 1.65e-05 | 8 | 18 | 2 | CID000062518 | |
| Drug | KT-89 | 1.65e-05 | 8 | 18 | 2 | CID005748450 | |
| Drug | Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone | 1.65e-05 | 8 | 18 | 2 | CID005492572 | |
| Drug | binaltorphimine | 1.65e-05 | 8 | 18 | 2 | CID005484197 | |
| Drug | AC1L1B1Q | 1.65e-05 | 8 | 18 | 2 | CID000001246 | |
| Drug | N-methyl nalorphine | 1.65e-05 | 8 | 18 | 2 | CID005748235 | |
| Drug | AC1LBBLW | 1.65e-05 | 8 | 18 | 2 | CID000579851 | |
| Drug | Tramadol | 2.12e-05 | 9 | 18 | 2 | DB00193 | |
| Drug | AC1LD4H9 | 2.12e-05 | 9 | 18 | 2 | CID000611919 | |
| Drug | meptazinol | 2.12e-05 | 9 | 18 | 2 | CID000041049 | |
| Drug | MRZ 2549 | 2.12e-05 | 9 | 18 | 2 | CID000134837 | |
| Drug | M 285 | 2.12e-05 | 9 | 18 | 2 | CID000020435 | |
| Disease | Mental Depression | 4.67e-04 | 254 | 18 | 3 | C0011570 | |
| Disease | Depressive disorder | 6.80e-04 | 289 | 18 | 3 | C0011581 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.08e-03 | 80 | 18 | 2 | DOID:12930 (implicated_via_orthology) | |
| Disease | Visual seizure | 1.71e-03 | 101 | 18 | 2 | C0270824 | |
| Disease | Epileptic drop attack | 1.71e-03 | 101 | 18 | 2 | C0270846 | |
| Disease | Generalized seizures | 1.71e-03 | 101 | 18 | 2 | C0234533 | |
| Disease | Clonic Seizures | 1.71e-03 | 101 | 18 | 2 | C0234535 | |
| Disease | Vertiginous seizure | 1.71e-03 | 101 | 18 | 2 | C0422855 | |
| Disease | Gustatory seizure | 1.71e-03 | 101 | 18 | 2 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.71e-03 | 101 | 18 | 2 | C0422850 | |
| Disease | Olfactory seizure | 1.71e-03 | 101 | 18 | 2 | C0422853 | |
| Disease | Seizures, Auditory | 1.71e-03 | 101 | 18 | 2 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.71e-03 | 101 | 18 | 2 | C4505436 | |
| Disease | Convulsive Seizures | 1.71e-03 | 101 | 18 | 2 | C0751494 | |
| Disease | Seizures, Sensory | 1.71e-03 | 101 | 18 | 2 | C0751496 | |
| Disease | Atonic Absence Seizures | 1.71e-03 | 101 | 18 | 2 | C0751123 | |
| Disease | Complex partial seizures | 1.71e-03 | 101 | 18 | 2 | C0149958 | |
| Disease | Single Seizure | 1.71e-03 | 101 | 18 | 2 | C0751110 | |
| Disease | Epileptic Seizures | 1.71e-03 | 101 | 18 | 2 | C4317109 | |
| Disease | Jacksonian Seizure | 1.71e-03 | 101 | 18 | 2 | C0022333 | |
| Disease | Non-epileptic convulsion | 1.71e-03 | 101 | 18 | 2 | C0751056 | |
| Disease | Nonepileptic Seizures | 1.71e-03 | 101 | 18 | 2 | C3495874 | |
| Disease | Tonic Seizures | 1.75e-03 | 102 | 18 | 2 | C0270844 | |
| Disease | Absence Seizures | 1.75e-03 | 102 | 18 | 2 | C4316903 | |
| Disease | Convulsions | 1.75e-03 | 102 | 18 | 2 | C4048158 | |
| Disease | Seizures, Focal | 1.81e-03 | 104 | 18 | 2 | C0751495 | |
| Disease | Myoclonic Seizures | 1.81e-03 | 104 | 18 | 2 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.81e-03 | 104 | 18 | 2 | C0494475 | |
| Disease | Cocaine-Related Disorders | 2.29e-03 | 117 | 18 | 2 | C0236736 | |
| Disease | Cocaine Abuse | 2.69e-03 | 127 | 18 | 2 | C0009171 | |
| Disease | Cocaine Dependence | 3.21e-03 | 139 | 18 | 2 | C0600427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TMVVVICVIVLNIHF | 321 | Q07001 | |
| IMVPVGLVFVAFALH | 251 | Q9BRQ5 | |
| EVVIIVFALFVMPAC | 196 | Q8NGE9 | |
| VFALFVMPACILVIL | 201 | Q8NGE9 | |
| ICVFIFAFIMPVLII | 236 | P35372 | |
| HIIVVVLFFVPCIFV | 241 | Q96R67 | |
| HIIVVALVFVPCIFM | 241 | Q8NH70 | |
| ICCIVMIVFPVAIII | 201 | Q8NG83 | |
| EKVLFICCIVMIVFP | 196 | A3KFT3 | |
| ICCIVMIVFPVAIII | 201 | A3KFT3 | |
| PALLCVVIFVVFLMA | 56 | Q8NH00 | |
| HIIVVILFFGPCIFI | 241 | Q6IEV9 | |
| IVICLMVIFLGTLVH | 11 | Q9HBE4 | |
| HIIVVILFFGPCIFM | 241 | Q8NGL9 | |
| MKICVFIFAFVIPVL | 226 | P41145 | |
| HFIMVILFFVPCIFL | 241 | P0C604 | |
| HVIMLFVPVTLCMVV | 81 | P49768 | |
| FVPVTLCMVVVVATI | 86 | P49768 | |
| FLALMVIAIPLCVVV | 206 | Q8NGX8 | |
| MAVAVFLVICIVVVV | 466 | O43278 | |
| PVVHPVMIAVCCFLI | 61 | O95859 | |
| EPIVKSFHFVCLMII | 6 | Q9Y2C9 | |
| VVVFHFLVPMIIVIF | 191 | P48039 |